Teva Pharmaceutical Industries Limited (TEVA)
USD 21.2
(1.53%)
USD 21.2
(1.53%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 18.48 Billion USD | -4.99% |
| 2022 | 19.45 Billion USD | -11.71% |
| 2021 | 22.03 Billion USD | -5.07% |
| 2020 | 23.21 Billion USD | -7.15% |
| 2019 | 24.99 Billion USD | -6.38% |
| 2018 | 26.7 Billion USD | -7.38% |
| 2017 | 28.82 Billion USD | -11.36% |
| 2016 | 32.52 Billion USD | 287.98% |
| 2015 | 8.38 Billion USD | -2.14% |
| 2014 | 8.56 Billion USD | -17.53% |
| 2013 | 10.38 Billion USD | -11.31% |
| 2012 | 11.71 Billion USD | 14.42% |
| 2011 | 10.23 Billion USD | 149.84% |
| 2010 | 4.09 Billion USD | -18.68% |
| 2009 | 5.03 Billion USD | -9.01% |
| 2008 | 5.53 Billion USD | 65.43% |
| 2007 | 3.34 Billion USD | -27.0% |
| 2006 | 4.58 Billion USD | 158.56% |
| 2005 | 1.77 Billion USD | 17.17% |
| 2004 | 1.51 Billion USD | 85.6% |
| 2003 | 815.4 Million USD | -29.79% |
| 2002 | 1.16 Billion USD | -6.86% |
| 2001 | 1.24 Billion USD | 53.2% |
| 2000 | 813.89 Million USD | 107.93% |
| 1999 | 391.41 Million USD | 94.06% |
| 1998 | 201.7 Million USD | 55.27% |
| 1997 | 129.9 Million USD | -19.37% |
| 1996 | 161.1 Million USD | 294.85% |
| 1995 | 40.8 Million USD | -49.5% |
| 1994 | 80.8 Million USD | 16.59% |
| 1993 | 69.3 Million USD | 87.3% |
| 1992 | 37 Million USD | -36.1% |
| 1991 | 57.9 Million USD | -15.6% |
| 1990 | 68.6 Million USD | 3.16% |
| 1989 | 66.5 Million USD | 66.67% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 16.58 Billion USD | -8.68% |
| 2024 Q2 | 16.54 Billion USD | -0.22% |
| 2023 Q1 | 20.01 Billion USD | 2.88% |
| 2023 Q3 | 18.81 Billion USD | -1.14% |
| 2023 Q2 | 19.03 Billion USD | -4.88% |
| 2023 Q4 | 18.48 Billion USD | -1.8% |
| 2023 FY | 18.48 Billion USD | -4.99% |
| 2022 Q4 | 19.45 Billion USD | 3.19% |
| 2022 Q1 | 21.23 Billion USD | -3.63% |
| 2022 Q2 | 20.73 Billion USD | -2.35% |
| 2022 FY | 19.45 Billion USD | -11.71% |
| 2022 Q3 | 18.85 Billion USD | -9.08% |
| 2021 Q2 | 22.04 Billion USD | -3.0% |
| 2021 Q1 | 22.72 Billion USD | -2.07% |
| 2021 Q4 | 22.03 Billion USD | 2.66% |
| 2021 Q3 | 21.46 Billion USD | -2.64% |
| 2021 FY | 22.03 Billion USD | -5.07% |
| 2020 Q2 | 25.03 Billion USD | 0.59% |
| 2020 Q3 | 23.98 Billion USD | -4.17% |
| 2020 Q1 | 24.88 Billion USD | -0.45% |
| 2020 Q4 | 23.21 Billion USD | -3.24% |
| 2020 FY | 23.21 Billion USD | -7.15% |
| 2019 Q4 | 24.99 Billion USD | 3.27% |
| 2019 Q2 | 26.38 Billion USD | 0.47% |
| 2019 FY | 24.99 Billion USD | -6.38% |
| 2019 Q1 | 26.25 Billion USD | -1.66% |
| 2019 Q3 | 24.2 Billion USD | -8.24% |
| 2018 Q2 | 28.96 Billion USD | -1.65% |
| 2018 Q1 | 29.45 Billion USD | 2.15% |
| 2018 FY | 26.7 Billion USD | -7.38% |
| 2018 Q4 | 26.7 Billion USD | -0.43% |
| 2018 Q3 | 26.81 Billion USD | -7.42% |
| 2017 Q1 | 32.69 Billion USD | 0.52% |
| 2017 Q3 | 31.97 Billion USD | -5.43% |
| 2017 FY | 28.82 Billion USD | -11.36% |
| 2017 Q2 | 33.8 Billion USD | 3.4% |
| 2017 Q4 | 28.82 Billion USD | -9.83% |
| 2016 Q1 | 8.61 Billion USD | 2.82% |
| 2016 FY | 32.52 Billion USD | 287.98% |
| 2016 Q3 | 33.17 Billion USD | 312.88% |
| 2016 Q4 | 32.52 Billion USD | -1.97% |
| 2016 Q2 | 8.03 Billion USD | -6.76% |
| 2015 Q3 | 9.51 Billion USD | 0.21% |
| 2015 FY | 8.38 Billion USD | -2.14% |
| 2015 Q2 | 9.49 Billion USD | 1.12% |
| 2015 Q1 | 9.39 Billion USD | 9.63% |
| 2015 Q4 | 8.38 Billion USD | -11.91% |
| 2014 Q2 | 9.12 Billion USD | -10.95% |
| 2014 Q1 | 10.24 Billion USD | -1.38% |
| 2014 Q4 | 8.56 Billion USD | -2.86% |
| 2014 FY | 8.56 Billion USD | -17.53% |
| 2014 Q3 | 8.81 Billion USD | -3.33% |
| 2013 Q1 | 9.93 Billion USD | -15.15% |
| 2013 Q2 | 9.92 Billion USD | -0.13% |
| 2013 FY | 10.38 Billion USD | -11.31% |
| 2013 Q4 | 10.38 Billion USD | 3.24% |
| 2013 Q3 | 10.06 Billion USD | 1.37% |
| 2012 FY | 11.71 Billion USD | 14.42% |
| 2012 Q1 | 10.15 Billion USD | -0.77% |
| 2012 Q4 | 11.71 Billion USD | -7.69% |
| 2012 Q2 | 12.62 Billion USD | 24.3% |
| 2012 Q3 | 12.68 Billion USD | 0.5% |
| 2011 Q2 | 3.92 Billion USD | -19.62% |
| 2011 Q1 | 4.87 Billion USD | 18.66% |
| 2011 Q4 | 10.23 Billion USD | 134.5% |
| 2011 Q3 | 4.36 Billion USD | 11.35% |
| 2011 FY | 10.23 Billion USD | 149.84% |
| 2010 Q1 | 4.13 Billion USD | -4.01% |
| 2010 Q4 | 4.11 Billion USD | -13.29% |
| 2010 Q3 | 4.74 Billion USD | -6.53% |
| 2010 Q2 | 5.07 Billion USD | 22.55% |
| 2010 FY | 4.09 Billion USD | -18.68% |
| 2009 FY | 5.03 Billion USD | -9.01% |
| 2009 Q2 | 5.37 Billion USD | -5.77% |
| 2009 Q3 | 4.97 Billion USD | -7.48% |
| 2009 Q4 | 4.31 Billion USD | -13.28% |
| 2009 Q1 | 5.7 Billion USD | 2.98% |
| 2008 Q2 | 3.32 Billion USD | -0.81% |
| 2008 Q1 | 3.34 Billion USD | 0.03% |
| 2008 FY | 5.53 Billion USD | 65.43% |
| 2008 Q3 | 3.91 Billion USD | 17.92% |
| 2008 Q4 | 5.53 Billion USD | 41.39% |
| 2007 Q1 | 4 Billion USD | -12.63% |
| 2007 Q2 | 3.98 Billion USD | -0.62% |
| 2007 Q3 | 3.35 Billion USD | -15.65% |
| 2007 Q4 | 3.34 Billion USD | -0.33% |
| 2007 FY | 3.34 Billion USD | -27.0% |
| 2006 FY | 4.58 Billion USD | 158.56% |
| 2006 Q3 | 4.67 Billion USD | 1.85% |
| 2006 Q4 | 4.58 Billion USD | -1.83% |
| 2006 Q1 | 4.59 Billion USD | 159.19% |
| 2006 Q2 | 4.58 Billion USD | -0.23% |
| 2005 Q2 | 1.51 Billion USD | 0.0% |
| 2005 Q1 | 1.51 Billion USD | 0.0% |
| 2005 FY | 1.77 Billion USD | 17.17% |
| 2005 Q4 | 1.77 Billion USD | 17.18% |
| 2005 Q3 | 1.51 Billion USD | -0.01% |
| 2004 Q4 | 1.51 Billion USD | -12.51% |
| 2004 Q3 | 1.72 Billion USD | -7.17% |
| 2004 Q2 | 1.86 Billion USD | -1.9% |
| 2004 Q1 | 1.89 Billion USD | 132.95% |
| 2004 FY | 1.51 Billion USD | 85.6% |
| 2003 Q4 | 815.4 Million USD | 81.2% |
| 2003 Q3 | 450 Million USD | -44.44% |
| 2003 Q2 | 810 Million USD | -30.33% |
| 2003 Q1 | 1.16 Billion USD | 0.1% |
| 2003 FY | 815.4 Million USD | -29.79% |
| 2002 Q3 | 1.25 Billion USD | -1.82% |
| 2002 Q2 | 1.27 Billion USD | 2.04% |
| 2002 Q1 | 1.25 Billion USD | 0.44% |
| 2002 FY | 1.16 Billion USD | -6.86% |
| 2002 Q4 | 1.16 Billion USD | -7.44% |
| 2001 Q4 | 1.24 Billion USD | -0.25% |
| 2001 FY | 1.24 Billion USD | 53.2% |
| 2001 Q1 | 806.61 Million USD | -0.89% |
| 2001 Q2 | 801.92 Million USD | -0.58% |
| 2001 Q3 | 1.25 Billion USD | 55.87% |
| 2000 Q1 | 388.77 Million USD | -0.68% |
| 2000 FY | 813.89 Million USD | 107.93% |
| 2000 Q2 | 368.36 Million USD | -5.25% |
| 2000 Q4 | 813.89 Million USD | 0.0% |
| 2000 Q3 | - USD | -100.0% |
| 1999 Q2 | 203.6 Million USD | 1.14% |
| 1999 Q3 | 308.3 Million USD | 51.42% |
| 1999 Q4 | 391.41 Million USD | 26.96% |
| 1999 FY | 391.41 Million USD | 94.06% |
| 1999 Q1 | 201.3 Million USD | -0.2% |
| 1998 Q3 | 202.1 Million USD | 0.9% |
| 1998 Q2 | 200.3 Million USD | 77.1% |
| 1998 Q1 | 113.1 Million USD | -12.93% |
| 1998 Q4 | 201.7 Million USD | -0.2% |
| 1998 FY | 201.7 Million USD | 55.27% |
| 1997 Q4 | 129.9 Million USD | 0.0% |
| 1997 FY | 129.9 Million USD | -19.37% |
| 1996 Q4 | 161.1 Million USD | 0.0% |
| 1996 FY | 161.1 Million USD | 294.85% |
| 1995 FY | 40.8 Million USD | -49.5% |
| 1995 Q4 | 40.8 Million USD | 0.0% |
| 1994 FY | 80.8 Million USD | 16.59% |
| 1994 Q4 | 80.8 Million USD | 0.0% |
| 1993 FY | 69.3 Million USD | 87.3% |
| 1993 Q4 | 69.3 Million USD | 0.0% |
| 1992 Q4 | 37 Million USD | 0.0% |
| 1992 FY | 37 Million USD | -36.1% |
| 1991 FY | 57.9 Million USD | -15.6% |
| 1991 Q4 | 57.9 Million USD | 0.0% |
| 1990 Q4 | 68.6 Million USD | 0.0% |
| 1990 FY | 68.6 Million USD | 3.16% |
| 1989 FY | 66.5 Million USD | 66.67% |
| 1989 Q4 | 66.5 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Amneal Pharmaceuticals, Inc. | 2.52 Billion USD | -632.53% |
| Bausch Health Companies Inc. | 21.93 Billion USD | 15.758% |
| Catalent, Inc. | 4.54 Billion USD | -306.623% |
| Emergent BioSolutions Inc. | 446.5 Million USD | -4039.082% |
| Elanco Animal Health Incorporated | 5.73 Billion USD | -222.193% |
| Perrigo Company plc | 3.63 Billion USD | -408.726% |
| Zoetis Inc. | 6.56 Billion USD | -181.551% |